Chemistry

Ron Magolida Medical Products Department E.I. du Pont de Nemours & Co. Wilmington, Del. The biosynthesis and inhibition of prostacyclin and thromboxane A2 has for almost two decades attracted tremendous interest in both the biological and chemical community. A recent paper presents evidence for the biosynthesis of these important biomolecules via a cage radical mechanism. M. Hecker, V. Ullrich, "On the mechanism of prostacyclin and thromboxane A2 biosynthesis," Journal of Biological Chemistr

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Ron Magolida
Medical Products Department E.I. du Pont de Nemours & Co.
Wilmington, Del.

The biosynthesis and inhibition of prostacyclin and thromboxane A2 has for almost two decades attracted tremendous interest in both the biological and chemical community. A recent paper presents evidence for the biosynthesis of these important biomolecules via a cage radical mechanism.

M. Hecker, V. Ullrich, "On the mechanism of prostacyclin and thromboxane A2 biosynthesis," Journal of Biological Chemistry, 264 (1), 141-150, 5 January 1989.

" An efficient and practical intramolecular photochemical approach for the preparation of nitrogen heterocycles has been identified.

W. Xu, Y.T. Jeon, E. Hasegawa, U.C. Yoon, P.S. Mariano, "Novel electron-transfer photocyclization reactions of alpha-silyl amine alpha, beta-unsaturated ketone and ester systems," Journal of the American Chemical Society, 111 (1), 406-8, 4 January 1989.

" Three new compounds with antibiotic activity have been isolated from a plant source.

H. Jayasuriya, J.D. McChesney, "Drummondins A-C: ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies